• 1
    Boskey AL, Wright TM, Blank RD 1999 Collagen and bone strength. J Bone Miner Res 14:330335.
  • 2
    Batge B, Deibold J, Stein H, Bodo M, Muller PK 1992 Compositional analysis of the collagenous bone matrix—a study on adult normal and osteopenic bone tissue. Eur J Clin Invest 22:805812.
  • 3
    Kowitz J, Knippel M, Schuhr T, Mach J 1997 Alteration in the extent of collagen I hydroxylation, isolated from femoral heads of women with a femoral neck fracture caused by osteoporosis. Calcif Tissue Int 60:501505.
  • 4
    Oxlund H, Moselkilde L, Ortoft G 1996 Reduced concentration of collagen reducible cross-links in human trabecular bone with respect to age and osteoporosis. Bone 19:479484.
  • 5
    Fledelius C, Johnsen AH, Cloos PAC, Bonde M, Qvist P 1997 Characterization of urinary degradation products derived from type I collagen. J Biol Chem 272:97559763.
  • 6
    Cloos PAC, Fledelius C 2000 Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: A biological clock of protein aging with clinical potential. Biochem J 345:473480.
  • 7
    Garnero P, Fledelius C, Gineyts E, Serre C-M, Vignot E, Delmas PD 1997 Decreased β isomerization of C-telopeptides of type I collagen in Paget's disease of bone. J Bone Miner Res 12:14071415.
  • 8
    Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T 1999 The relationships between the degree of β-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis fractures. Osteoporos Int 9:405409.
  • 9
    Garnero P, Sornay-Rendu E, Chapuy M-C, Delmas PD 1996 Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337349.
  • 10
    Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD 1997 Apparent pre and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: The OFELY cohort. J Bone Miner Res 12:683690.
  • 11
    National Osteoporosis foundation Working Group on Vertebral Fractures 1995 Assessing vertebral fractures: A report by the National Osteoporosis Working Group on Vertebral Fractures. J Bone Miner Res 10:518523.
  • 12
    Black DM, Palermo L, Nevitt MC, Genant HK, Christensen L, Cummings SR 1999 Defining incident vertebral deformity: A prospective comparison of several approaches. J Bone Miner Res 14:90101.
  • 13
    Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C 1994 Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:20222025.
  • 14
    Garnero P, Delmas PD 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:10461053.
  • 15
    Kanis JA, Johnell O, Oden A, Jonsson B, Dawson A, Dere W 2000 Risk factor for hip fracture derived from relative risks: An analysis applied to the population of Sweden. Osteoporos Int 11:120127.
  • 16
    SAS Institute 1996 SAS STAT Users's Guide, version 6, 4th ed., vols. 1 and 2. SAS Institute, Cary, NC, USA.
  • 17
    van Daele PLA, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JPTM, Birkenhager JC, Pols HAP 1996 Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam Study. BMJ 312:482483.
  • 18
    Garnero P, Hausher E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res 11:15311538.
  • 19
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY Study. J Bone Miner Res 8:15261536.
  • 20
    Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA 2000 Serum Bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study. Osteoporos Int 11:7682.
  • 21
    Martin RB, Ishida J 1989 The relative contribution of collagen fiber orientation, porosity, density, and mineralisation on bone strength. J Biomech 22:419426.
  • 22
    Shapiro JR, Burn VE, Chipman SD, Velis KP, Bansal M 1989 Osteoporosis and familial idiopathic scoliosis: Association with an abnormal alpha 2 (I) collagen. Connect Tissue Res 21:117123.
  • 23
    Shapiro JR, Stover ML, Burn VE, McKinstry MB, Burshell Al, Chipman SD, Rowe DW 1992 An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for a glycine at the triple helix position 43 in the pro alpha 1 (I) chain of type I collagen. J Clin Invest 89:567573.
  • 24
    Spotila LD, Colige A, Sereda L, Constantinou-Delta, Whyte MP, Riggs BL, Shaker JL, Spector TD, Hume E, Olsen N, Attie M, Tenenhouse A, Shane E, Briney W, Prockop DJ 1994 Mutation analysis of coding sequences for type I procollagen in individuals with low bone density. J Bone Miner Res 9:923932.
  • 25
    Paterson CR, Mole PA 1994 Bone density in osteogenesis imperfecta may well be normal. Postgrad Med J 70:104107.
  • 26
    Hol WGJ, Halie LM, Sandeer C 1981 Dipoles of the α-helix and β-sheet, their role in protein folding. Nature 294:532536.
  • 27
    Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon M, Zürcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD 1993 Structural alterations in the peptide backbone β-amyloid core protein may account for its deposition and stability in Alzheimer Disease. J Biol Chem 268:30723083.
  • 28
    Tomiyama T, Asano S, Fuiya Y, Shrisawa T, Endo N, Mori H 1994 Racemization of Asp23 residue affects the aggregation of Alzheimer amyloid beta protein analogues. J Biol Chem 268:1020510208.